|
|
Article: District Court Rules in Favor of Dey in Abbott Laboratories Lawsuit to Stop The Sale of Life-Saving Pulmonary Surfactant.
- Article from:
- PR Newswire
- Article date:
- May 24, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN FRANCISCO, May 24 /PRNewswire/ --
The United States District Court for the Northern District of Illinois has granted summary judgment in favor of Dey, LP and Dey, Inc. in a lawsuit brought by Abbott Laboratories to stop the sale of Curosurf(R), a life-saving pulmonary surfactant that is used to treat infant respiratory distress syndrome (IRDS), the leading cause of death in premature babies. Abbott markets a corresponding surfactant, Survanta(R), and was alleging patent infringement.
Dey is a specialty pharmaceutical company headquartered in Napa, Ca., that develops, manufactures and markets prescription drug products for the treatment of ...